Drug Shortage Report for SOLU-MEDROL

Last updated on 2023-05-17 History
Report ID 187129
Drug Identification Number 02367963
Brand name SOLU-MEDROL
Common or Proper name SOLU-MEDROL
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) METHYLPREDNISOLONE
Strength(s) 500MG
Dosage form(s) POWDER FOR SOLUTION KIT
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 5 x 4mL vial
ATC code H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-04-12
Estimated end date
Actual end date 2023-05-16
Shortage status Resolved
Updated date 2023-05-17
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2023-05-17 English Compare
v7 2023-05-16 French Compare
v6 2023-05-16 English Compare
v5 2023-04-13 English Compare
v4 2023-04-12 French Compare
v3 2023-04-12 English Compare
v2 2023-03-15 French Compare
v1 2023-03-15 English Compare

Showing 1 to 8 of 8